Veterinary Medicines Information website

Nobilis ND Clone 30 live lyophilisate for oculonasal suspension/use in drinking water for chickens and turkeys.

Authorised
  • Newcastle disease virus, strain Clone 30, Live
Download as PDF

Product identification

Medicine name:
Nobilis ND Clone 30 live lyophilisate for oculonasal suspension/use in drinking water for chickens and turkeys.
Active substance:
  • Newcastle disease virus, strain Clone 30, Live
Target species:
  • Turkey
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Live
    1258930000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Turkey
      • Meat and offal
        0
        day
    • Chicken
      • Eggs
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • PET plastic box with 12 sealed aluminium laminate cups with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Contents per cup: 1000 doses
  • PET plastic box with 12 sealed aluminium laminate cups with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Contents per cup: 2500 doses
  • PET plastic box with 12 sealed aluminium laminate cups with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Contents per cup: 5000 doses
  • PET plastic box with 6 sealed aluminium laminate cups with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Contents per cup: 10000 doses
  • Cardboard box containing 1 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 500 doses.
  • Cardboard box containing 10 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 500 doses.
  • Cardboard box containing 50 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 500 doses.
  • Cardboard box containing 1 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 1000 doses.
  • Cardboard box containing 10 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 1000 doses.
  • Cardboard box containing 50 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 1000 doses.
  • Cardboard box containing 1 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 2000 doses.
  • Cardboard box containing 10 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 2000 doses.
  • Cardboard box containing 50 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 2000 doses.
  • Cardboard box containing 1 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 2500 doses.
  • Cardboard box containing 10 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 2500 doses.
  • Cardboard box containing 50 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 2500 doses.
  • Cardboard box containing 1 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 3000 doses.
  • Cardboard box containing 10 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 3000 doses.
  • Cardboard box containing 50 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 3000 doses.
  • Cardboard box containing 1 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 5000 doses.
  • Cardboard box containing 10 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 5000 doses.
  • Cardboard box containing 50 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 5000 doses.
  • Cardboard box containing 1 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 10000 doses.
  • Cardboard box containing 10 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 10000 doses.
  • Cardboard box containing 50 vials of 10 ml glass (hydrolytic glass type I) with halogenobutyl rubber stopper andaluminium cap.Contents per vial: 10000 doses.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/091/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 29/03/2026
Download